143 related articles for article (PubMed ID: 36370087)
1. Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
Molina JC; Li Y; Otto WR; Miller TP; Getz KD; Mccoubrey C; Ramos M; Krause E; Cao L; Gramatges MM; Rabin K; Scheurer M; Elgarten CW; Myers RM; Seif AE; Fisher BT; Shah NN; Aplenc R
Pediatr Blood Cancer; 2023 Jan; 70(1):e30062. PubMed ID: 36370087
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.
Ceppi F; Rivers J; Annesley C; Pinto N; Park JR; Lindgren C; Mgebroff S; Linn N; Delaney M; Gardner RA
Transfusion; 2018 Jun; 58(6):1414-1420. PubMed ID: 29536556
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
[TBL] [Abstract][Full Text] [Related]
4. Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells.
Liu Y; Chen W; Yu M; Li H; Cheng H; Cao J; Yan Z; Shi M; Zhu F; Sun H; Sang W; Li D; Wu Q; Chen C; Zheng J; Xu K; Li Z
Transplant Cell Ther; 2022 Feb; 28(2):118.e1-118.e5. PubMed ID: 34861455
[TBL] [Abstract][Full Text] [Related]
5. CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Cui Q; Qian C; Xu N; Kang L; Dai H; Cui W; Song B; Yin J; Li Z; Zhu X; Qu C; Liu T; Shen W; Zhu M; Yu L; Wu D; Tang X
J Hematol Oncol; 2021 May; 14(1):82. PubMed ID: 34034795
[TBL] [Abstract][Full Text] [Related]
6. Haematology laboratory parameters to assess efficacy of CD19-, CD22-, CD33-, and CD123-directed chimeric antigen receptor T-cell therapy in haematological malignancies.
Drumheller B; Gebre K; Lockhart B; Margolskee E; Obstfeld A; Paessler M; Pillai V
Int J Lab Hematol; 2022 Aug; 44(4):750-758. PubMed ID: 35419923
[TBL] [Abstract][Full Text] [Related]
7. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
[TBL] [Abstract][Full Text] [Related]
8. Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
Michelis FV; Messner HA; Loach D; Uhm J; Gupta V; Lipton JH; Seftel MD; Kuruvilla J; Kim DD
Eur J Haematol; 2014 Oct; 93(4):273-80. PubMed ID: 24725056
[TBL] [Abstract][Full Text] [Related]
9. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
[TBL] [Abstract][Full Text] [Related]
10. Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.
Qin H; Yang L; Chukinas JA; Shah N; Tarun S; Pouzolles M; Chien CD; Niswander LM; Welch AR; Taylor N; Tasian SK; Fry TJ
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531250
[TBL] [Abstract][Full Text] [Related]
11. Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia.
Han DK; Baek HJ; Kim SY; Hwang TJ; Kook H
Yonsei Med J; 2013 Jan; 54(1):62-70. PubMed ID: 23225800
[TBL] [Abstract][Full Text] [Related]
12. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
13. Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia.
Le Jeune C; Bertoli S; Elhamri M; Vergez F; Borel C; Huguet F; Michallet M; Dumontet C; Recher C; Thomas X
Leuk Lymphoma; 2014 Apr; 55(4):855-62. PubMed ID: 23786457
[TBL] [Abstract][Full Text] [Related]
14. Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.
Bar M; Othus M; Park HM; Sandhu V; Chen X; Wood BL; Estey E
Leuk Lymphoma; 2015; 56(11):3109-15. PubMed ID: 25726954
[TBL] [Abstract][Full Text] [Related]
15. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia.
Porrata LF; Litzow MR; Tefferi A; Letendre L; Kumar S; Geyer SM; Markovic SN
Leukemia; 2002 Jul; 16(7):1311-8. PubMed ID: 12094255
[TBL] [Abstract][Full Text] [Related]
16. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells.
Lu Y; Zhu H; Liu Y; Wang Y; Sun Y; Cheng H; Yan Z; Cao J; Sang W; Zhu F; Li D; Sun H; Zheng J; Xu K; Li Z
Front Immunol; 2023; 14():1155216. PubMed ID: 37205117
[TBL] [Abstract][Full Text] [Related]
18. Early lymphocyte recovery predicts superior outcomes after unmanipulated haploidentical blood and marrow transplant for acute myeloid leukemia.
Fu Q; Xu LP; Zhang XH; Wang Y; Chang YJ; Huang XJ
Clin Transplant; 2016 Aug; 30(8):954-8. PubMed ID: 27219272
[TBL] [Abstract][Full Text] [Related]
19. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
Front Immunol; 2021; 12():755549. PubMed ID: 34777367
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma.
Galvez-Silva J; Maher OM; Park M; Liu D; Hernandez F; Tewari P; Nieto Y
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1276-1281. PubMed ID: 28435146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
